Liu Hui
Vermogen: 207 157 $ op 30-09-2026
Vermogen: 207 157 $ op 30-09-2026
Dr. Liu Hui is an Independent Director at Rallybio Corp.
He is on the Board of Directors at Rallybio Corp.
Dr. Hui was previously employed as a Chief Business Officer & Executive Vice President by Merus NV and a VP & Head-Business Development & Licensing by Novartis AG.
He received his undergraduate degree from Peking University, an MBA from the University of Michigan and a doctorate degree from the University of Michigan.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
RALLYBIO CORPORATION 0,23% | 24-09-2026 | 12.044 ( 0,23% ) | 207 157 $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| RALLYBIO CORPORATION | Directeur/Bestuurslid | 04-04-2022 |
| Bedrijven | Functie | Einde |
|---|---|---|
| MERUS N.V. | Corporate Officer/Principal | 01-07-2024 |
| NOVARTIS AG | Corporate Officer/Principal | 01-01-2015 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Peking University
Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merus NV
Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Rallybio Corp.
Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau